|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stem Cell Genetics and Genomics |
1 Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany
2 Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany; Department of Bioscience and Biotechnology, Bio-Organ Research Center, Konkuk University, Seoul, South Korea
3 Department of Bioscience and Biotechnology, Bio-Organ Research Center, Konkuk University, Seoul, South Korea
* To whom correspondence should be addressed. E-mail: schoeler{at}mpi-muenster.mpg.de.
| Abstract |
|---|
Pluripotent cells have been suggested as a prime source to reprogram somatic cells. We used F9 EC cells as a pluripotent partner to reprogram neurosphere cells (NSCs), because they exhibit a non-neural differentiation potential in the presence of retinoic acid. F9-NSC hybrid cells displayed various features of reprogramming, such as reactivation of pluripotency genes, inactivation of tissue-specific genes, and reactivation of the inactive X chromosome. As the hybrid cells undergo differentiation, the pluripotency markers Oct4 and Nanog were downregulated. While neural marker genes were not upregulated, endodermal and mesodermal markers were, suggesting that NSCs lose memory of their neural origin and preferentially differentiate to the lineages corresponding to the F9 program. After fusion, the methylation status in the Xist region was similar to that of F9 EC cells. However, upon differentiation the Xist region failed to resume the methylation patterns of differentiated cells, suggesting that the Xist in F9-NSC hybrids does not easily acquire a differentiated state.
Key Words. differentiation, F9 EC cells, fusion, Oct4, Xist, reprogramming
This article has been cited by other articles:
![]() |
J. T. Do, D. W. Han, L. Gentile, I. Sobek-Klocke, M. Stehling, and H. R. Scholer Enhanced Reprogramming of Xist by Induced Upregulation of Tsix and Dnmt3a Stem Cells, November 1, 2008; 26(11): 2821 - 2831. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cantz, G. Key, M. Bleidissel, L. Gentile, D. W. Han, A. Brenne, and H. R. Scholer Absence of OCT4 Expression in Somatic Tumor Cell Lines Stem Cells, March 1, 2008; 26(3): 692 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Han, J. T. Do, L. Gentile, M. Stehling, H. T. Lee, and H. R. Scholer Pluripotential Reprogramming of the Somatic Genome in Hybrid Cells Occurs with the First Cell Cycle Stem Cells, February 1, 2008; 26(2): 445 - 454. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
